Funding boost for Australian disease detection centre
This article was originally published in Clinica
The Australian Biosecurity Co-operative Research Centre (AB-CRC) targets early disease detection and identification with a number of innovative products, including implantable chips, hand-held devices and satellite information systems. Over the next seven years it is likely to attract more than Aus$8m (US$5.6m) in external funding for further collaborative and multidisciplinary research and education programme, it claims.
You may also be interested in...
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.